The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden

被引:4
|
作者
Isitt, Catherine [1 ,2 ]
Sjoholm, Daniel [3 ]
Hergens, Maria-Pia [2 ,4 ]
Granath, Fredrik [3 ]
Naucler, Pontus [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[2] Karolinska Inst, Dept Med Solna, Div Infect Dis, Solna, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Clin Epidemiol Unit, Solna, Sweden
[4] Stockholm Cty Council, Dept Communicable Dis Control & Prevent, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
COVID-19; Vaccines; SARS-CoV2; Cohort study; Long-term-care-facilities;
D O I
10.1016/j.vaccine.2022.03.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination against SARS-CoV-2 started in Region Stockholm, Sweden in December 2020 with those in long-term care facilities or receiving home care vaccinated first followed by those aged over 80 years. In this population-based, retrospective cohort study, we performed a Poisson regression to model the expected incidence of infections and deaths which we compared to the observed incidence and compared this to an unvaccinated control group of those aged 18-79 years. The aim of this study was to measure the early impact of the vaccination programme in Region Stockholm. Infections and deaths reduced substantially amongst the first two groups targeted for SARS-CoV-2 vaccination with an estimated total 3112 infections prevented, and 854 deaths prevented in these two groups from 4 weeks after the introduction of vaccination through to 2nd May 2021. (c) 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:2823 / 2827
页数:5
相关论文
共 50 条
  • [1] Timing vaccination against SARS-CoV-2
    Barnoud, Coline
    Wang, Chen
    Scheiermann, Christoph
    [J]. CELL RESEARCH, 2021, 31 (11) : 1146 - 1147
  • [2] Timing vaccination against SARS-CoV-2
    Coline Barnoud
    Chen Wang
    Christoph Scheiermann
    [J]. Cell Research, 2021, 31 : 1146 - 1147
  • [3] Impact of Vaccination Against SARS-CoV-2 in Kidney Transplant Recipients
    Taylor, Marcelo
    Martinoia, Andrea
    Ciappa, Julio M.
    Torres, Monica
    Obregon, Liliana M.
    Mir Sabato, German A.
    [J]. TRANSPLANTATION, 2022, 106 (09) : S735 - S735
  • [4] Impact of Obesity on Vaccination to SARS-CoV-2
    Nasr, Michaella-Jana C.
    Geerling, Elizabeth
    Pinto, Amelia K.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    [J]. VACCINES, 2021, 9 (03) : 1 - 13
  • [6] Vaccination strategies against SARS-CoV-2: General impact on the development of the pandemic
    Gil de Miguel, Angel
    Gil-Prieto, Ruth
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 60 - 62
  • [7] Current state of vaccination against SARS-CoV-2
    Iking-Konert, Christof
    Specker, Christof
    Krueger, Klaus
    Schulze-Koops, Hendrik
    Aries, Peer
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (02): : 158 - 164
  • [8] Vaccination of susceptible animals against SARS-CoV-2
    Xiang, Bin
    Yang, Liangyu
    Ye, Zaijiao
    Ren, Tao
    Ye, Yu
    [J]. JOURNAL OF INFECTION, 2022, 84 (05) : E48 - E49
  • [9] Vaccination against SARS-CoV-2 in cancer patients
    von Lilienfeld-Toal, Marie
    Rieger, Christina
    Giesen, Nicola
    Woermann, Bernhard
    [J]. ONKOLOGE, 2021, 27 (07): : 691 - 696
  • [10] Immunity against SARS-CoV-2: walking to the vaccination
    Rodriguez Hernandez, Carmen
    Sanz Moreno, Juan Carlos
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (06) : 392 - 398